Literature DB >> 25867578

Clinical Factors Associated with Morbidity and Mortality in Patients Admitted with Sickle Cell Disease.

K Galloway-Blake1, M Reid2, C Walters3, J Jaggon4, M G Lee5.   

Abstract

OBJECTIVE: To determine the clinical factors associated with the length of hospitalization and mortality in patients with sickle cell disease (SCD).
METHODS: All patients with SCD admitted to the medical wards of the University Hospital of the West Indies, Jamaica, over a five-year period, January 1 to December 31, 2010, were reviewed. Data were extracted from hospital charts and comprised demographic and clinical information, investigations, interventions, duration of stay, pathological data and outcomes.
RESULTS: There were 105 patients reviewed; 84% were genotype Hb SS. Females accounted for 59% and males 41%. Overall mean age was 32.5 years (SD 13.7, range 12-66 years). The mean length of hospitalization was 10.2 days (SD 10.9, range 1-84 days). The main admission diagnoses were painful crisis, acute chest syndrome, severe anaemia, sepsis, hepatic sequestration, congestive cardiac failure and renal failure. The mean value for the following laboratory investigations were: haemoglobin 7.7 g/dL (SD 2.8), total white blood cell count 21.7 x 109/L (SD 14.2), platelet count 320 x 109/L (SD 191.9), blood urea 9.8 mmol/L (SD 11.9) and serum creatinine 198 umol/L (SD 267.9). Medical interventions included: blood transfusions in 20.9%, 55% received antibiotics and 74% received narcotic analgesia. There were 40 deaths with four autopsies done. The mortality rate for SCD was 38%. There were 189 repeat SCD admissions.
CONCLUSION: Sickle cell disease still carries a high morbidity and mortality in patients admitted to hospital. Recurrent admissions are a concern, as they impact on patient's morbidity and quality of life.

Entities:  

Year:  2015        PMID: 25867578      PMCID: PMC4668979          DOI: 10.7727/wimj.2014.012

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  20 in total

1.  The changing face of homozygous sickle cell disease: 102 patients over 60 years.

Authors:  G R Serjeant; B E Serjeant; K P Mason; I R Hambleton; C Fisher; D R Higgs
Journal:  Int J Lab Hematol       Date:  2008-07-17       Impact factor: 2.877

2.  Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns.

Authors:  G R Serjeant; B E Serjeant; M Forbes; R J Hayes; D R Higgs; H Lehmann
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

3.  Causes of death in sickle-cell disease in Jamaica.

Authors:  A N Thomas; C Pattison; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

4.  Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.

Authors:  W F Rosse; D Gallagher; T R Kinney; O Castro; H Dosik; J Moohr; W Wang; P S Levy
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

5.  Treatment of sickle cell anemia with hydroxyurea and erythropoietin.

Authors:  M A Goldberg; C Brugnara; G J Dover; L Schapira; S Charache; H F Bunn
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

6.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

7.  Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease.

Authors:  M S West; D Wethers; J Smith; M Steinberg
Journal:  J Clin Epidemiol       Date:  1992-08       Impact factor: 6.437

8.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

9.  Are there clinical phenotypes of homozygous sickle cell disease?

Authors:  Neal Alexander; Douglas Higgs; George Dover; Graham R Serjeant
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

10.  Relatively benign sickle-cell anaemia in 60 patients aged over 30 in the West Indies.

Authors:  G R Serjeant; R Richards; P R Barbor; P F Milner
Journal:  Br Med J       Date:  1968-07-13
View more
  6 in total

1.  Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.

Authors:  Sri L H Yeruva; Yonette Paul; Patricia Oneal; Mehdi Nouraie
Journal:  Hemoglobin       Date:  2016-09-18       Impact factor: 0.849

2.  Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.

Authors:  Can Boğa; Süheyl Asma; Göksel Leblebisatan; Nazan Şen; Anıl Tombak; Yusuf Ziya Demiroğlu; Mahmut Yeral; Şule Akın; Hasan Yeşilağaç; Mehmet Ali Habeşoğlu; Anış Arıboğan; Mutlu Kasar; Aslı Korur; Hakan Özdoğu
Journal:  Ann Hematol       Date:  2021-05-25       Impact factor: 3.673

3.  Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines.

Authors:  Shelly-Ann Williams; Shakel Henson; Shenese Trimmingham; Jill Newman; Julie Kanter
Journal:  Pan Afr Med J       Date:  2021-01-29

4.  Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia.

Authors:  Rehab Y Al-Ansari; Leena M Abdalla; Yasmin A Qomawi; Laila J Alromaih; Mohanad O Bakkar; Amal S Shilash; Nawaf Y Zakary
Journal:  J Family Community Med       Date:  2022-01-19

5.  Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.

Authors:  Ravi Vats; Silvia Liu; Junjie Zhu; Dhanunjay Mukhi; Egemen Tutuncuoglu; Nayra Cardenes; Sucha Singh; Tomasz Brzoska; Karis Kosar; Mikhil Bamne; Jude Jonassaint; Adeola Adebayo Michael; Simon C Watkins; Cheryl Hillery; Xiaochao Ma; Kari Nejak-Bowen; Mauricio Rojas; Mark T Gladwin; Gregory J Kato; Sadeesh Ramakrishnan; Prithu Sundd; Satdarshan Pal Monga; Tirthadipa Pradhan-Sundd
Journal:  Hepatology       Date:  2020-11-13       Impact factor: 17.425

6.  All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study.

Authors:  Kunjan Udani; Nayda Parisio-Poldiak; Julia Campbell; Victor Collier; Pooja Patel
Journal:  Cureus       Date:  2021-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.